Journal
/
Cancer Research
/
Automated Kinetic Imaging for Drug Assessment in Patient-Derived Tumor Organoids…
/
Analisi delle immagini nel software Gen5 per analizzare la risposta ai farmaci in organoidi derivati da pazienti utilizzando l'imaging multiplex su cellule vive…
JoVE Journal
Cancer Research
Cancer Research
É necessário ter uma assinatura JoVE para assistir este Faça login ou comece sua avaliação gratuita.
Analisi delle immagini nel software Gen5 per analizzare la risposta ai farmaci in organoidi derivati da pazienti utilizzando l'imaging multiplex su cellule vive
The JoVE video player is compatible with HTML5 and Adobe Flash. Older browsers that do not support HTML5 and the H.264 video codec will still use a Flash-based video player. We recommend downloading the newest version of Flash here, but we support all versions 10 and above.
If that doesn't help, please let us know.
Unable to load video. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
An unexpected error occurred. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
Click here for the English version
Article
DOI:
10.3791/201046-v
•
02:40 min
•
January 5th, 2024
Analisi delle immagini nel software Gen5 per analizzare la risposta ai farmaci in organoidi derivati da pazienti utilizzando l'imaging multiplex su cellule vive
Automated Kinetic Imaging for Drug Assessment in Patient-Derived Tumor Organoids
January 5th, 2024
•
Kaitriana E. Colling*1,2, Emily L. Symons*1, Lorenzo Buroni*3, Hiruni K. Sumanasiri1, Jessica Andrew-Udoh1, Emily Witt1,4, Haley A. Losh1, Abigail M. Morrison1, Kimberly K. Leslie5, Christopher J. Dunnill6, Johann S. de Bono3, Kristina W. Thiel1,7
1Department of Obstetrics and Gynecology, Carver College of Medicine, University of Iowa, 2Cancer Biology Graduate Program, Carver College of Medicine, University of Iowa, 3The Institute of Cancer Research: and the Royal Marsden NHS Foundation Trust, 4Department of Radiation Oncology, Carver College of Medicine, University of Iowa, 5Division of Molecular Medicine, Departments of Internal Medicine and Obstetrics and Gynecology, University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, 6Agilent Technologies, 7Holden Comprehensive Cancer Center, University of Iowa
* These authors contributed equally
